Shanghai Haixin Group Co Ltd B Cash Flow Conversion Efficiency
Shanghai Haixin Group Co Ltd B cash flow conversion efficiency. Based on the latest financial reports, Shanghai Haixin Group Co Ltd B (900917) has a cash flow conversion efficiency ratio of 0.002x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.56 Million) by net assets ($4.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shanghai Haixin Group Co Ltd B (2015–2025)
Cash flow conversion efficiency of Shanghai Haixin Group Co Ltd B from 2015 to 2025. This chart illustrates how Shanghai Haixin Group Co Ltd B's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Shanghai Haixin Group Co Ltd B stock price today for real-time trading data and today's change.
Shanghai Haixin Group Co Ltd B Cash Flow Conversion Ratio Explained
Shanghai Haixin Group Co Ltd B cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shanghai Haixin Group Co Ltd B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haixin Group Co Ltd B ranked by their cash flow conversion efficiency. Also see Shanghai Haixin Group Co Ltd B (900917) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kt Skylife
KO:053210
|
0.039x |
|
Endeavour Mining Corp
LSE:EDV
|
0.087x |
|
PT Mandiri Herindo Adiperkasa Tbk
JK:MAHA
|
-0.050x |
|
Definitive Healthcare Corp
NASDAQ:DH
|
0.007x |
|
Servotronics Inc
NYSE MKT:SVT
|
-0.067x |
|
Southern Hydropower JSC
VN:SHP
|
0.058x |
|
Lalin Property Public Company Limited
BK:LALIN
|
-0.017x |
|
Sound Point Meridian Capital, Inc.
NYSE:SPMC
|
0.253x |
Annual Cash Flow Conversion Efficiency for Shanghai Haixin Group Co Ltd B (2015–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Haixin Group Co Ltd B from 2015 to 2025. Review cash generation quality of Shanghai Haixin Group Co Ltd B to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.92 Billion | $117.69 Million | 0.024x | +38.99% |
| 2024-12-31 | $4.50 Billion | $77.52 Million | 0.017x | +298.48% |
| 2023-12-31 | $4.14 Billion | $-35.88 Million | -0.009x | -147.41% |
| 2022-12-31 | $4.02 Billion | $73.56 Million | 0.018x | -64.31% |
| 2021-12-31 | $4.28 Billion | $219.65 Million | 0.051x | +83.35% |
| 2020-12-31 | $4.38 Billion | $122.50 Million | 0.028x | +535.28% |
| 2019-12-31 | $4.05 Billion | $-26.02 Million | -0.006x | -141.97% |
| 2018-12-31 | $3.63 Billion | $55.50 Million | 0.015x | +354.26% |
| 2017-12-31 | $3.95 Billion | $13.31 Million | 0.003x | +173.71% |
| 2016-12-31 | $4.34 Billion | $-19.84 Million | -0.005x | +81.37% |
| 2015-12-31 | $4.80 Billion | $-117.88 Million | -0.025x | -- |
About Shanghai Haixin Group Co Ltd B
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics… Read more